Your browser doesn't support javascript.
loading
Initial biopsy Gleason score as a predictive marker for survival benefit in patients with castration-resistant prostate cancer treated with docetaxel: data from the TAX327 study.
van Soest, Robert J; de Morrée, Ellen S; Shen, Liji; Tannock, Ian F; Eisenberger, Mario A; de Wit, Ronald.
Afiliação
  • van Soest RJ; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands. Electronic address: r.vansoest@erasmusmc.nl.
  • de Morrée ES; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Shen L; Sanofi, Malvern, PA, USA.
  • Tannock IF; Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada.
  • Eisenberger MA; Department of Oncology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.
  • de Wit R; Department of Medical Oncology, Erasmus University Medical Center and Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Eur Urol ; 66(2): 330-6, 2014 Aug.
Article em En | MEDLINE | ID: mdl-23957945
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Adenocarcinoma / Taxoides / Neoplasias de Próstata Resistentes à Castração / Estadiamento de Neoplasias / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Adenocarcinoma / Taxoides / Neoplasias de Próstata Resistentes à Castração / Estadiamento de Neoplasias / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2014 Tipo de documento: Article